It was found that the expression of p65 S276D (a constitutively active form of NF-κB) was associated with a significant increase in the GRO-α promoter activity, while Egr1, CDP had no effect on promoter activity in the context of primary bladder cancer cells (Figure 3D). The gene discussed is NFKB1; the disease is urinary bladder cancer.